Tiziana Life Sciences (TLSA) Competitors $0.78 -0.06 (-6.85%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends TLSA vs. CYRX, NGNE, PROC, VYGR, DSGN, BTMD, CTNM, SLRN, KMDA, and CGCShould you be buying Tiziana Life Sciences stock or one of its competitors? The main competitors of Tiziana Life Sciences include Cryoport (CYRX), Neurogene (NGNE), Procaps Group (PROC), Voyager Therapeutics (VYGR), Design Therapeutics (DSGN), biote (BTMD), Contineum Therapeutics (CTNM), Acelyrin (SLRN), Kamada (KMDA), and Canopy Growth (CGC). These companies are all part of the "pharmaceutical products" industry. Tiziana Life Sciences vs. Cryoport Neurogene Procaps Group Voyager Therapeutics Design Therapeutics biote Contineum Therapeutics Acelyrin Kamada Canopy Growth Cryoport (NASDAQ:CYRX) and Tiziana Life Sciences (NASDAQ:TLSA) are both small-cap transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation. Do institutionals and insiders believe in CYRX or TLSA? 92.9% of Cryoport shares are owned by institutional investors. 10.1% of Cryoport shares are owned by company insiders. Comparatively, 39.8% of Tiziana Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor CYRX or TLSA? Cryoport received 146 more outperform votes than Tiziana Life Sciences when rated by MarketBeat users. Likewise, 65.05% of users gave Cryoport an outperform vote while only 63.58% of users gave Tiziana Life Sciences an outperform vote. CompanyUnderperformOutperformCryoportOutperform Votes24265.05% Underperform Votes13034.95% Tiziana Life SciencesOutperform Votes9663.58% Underperform Votes5536.42% Which has more volatility and risk, CYRX or TLSA? Cryoport has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500. Comparatively, Tiziana Life Sciences has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Which has stronger valuation & earnings, CYRX or TLSA? Tiziana Life Sciences has lower revenue, but higher earnings than Cryoport. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoport$226.11M1.72-$99.59M-$3.38-2.33Tiziana Life SciencesN/AN/A-$17.69MN/AN/A Does the media refer more to CYRX or TLSA? In the previous week, Cryoport had 1 more articles in the media than Tiziana Life Sciences. MarketBeat recorded 3 mentions for Cryoport and 2 mentions for Tiziana Life Sciences. Cryoport's average media sentiment score of 0.97 beat Tiziana Life Sciences' score of 0.50 indicating that Cryoport is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cryoport 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tiziana Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CYRX or TLSA more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to Cryoport's net margin of -70.08%. Tiziana Life Sciences' return on equity of 0.00% beat Cryoport's return on equity.Company Net Margins Return on Equity Return on Assets Cryoport-70.08% -13.35% -6.43% Tiziana Life Sciences N/A N/A N/A Do analysts rate CYRX or TLSA? Cryoport currently has a consensus target price of $12.29, suggesting a potential upside of 56.31%. Given Cryoport's stronger consensus rating and higher probable upside, research analysts clearly believe Cryoport is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cryoport 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCryoport beats Tiziana Life Sciences on 10 of the 15 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSA vs. The Competition Export to ExcelMetricTiziana Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$87.69M$6.57B$5.14B$9.08BDividend YieldN/A2.98%5.09%4.23%P/E RatioN/A10.5089.8217.18Price / SalesN/A195.801,116.21116.95Price / CashN/A57.1642.8937.86Price / Book15.505.094.784.78Net Income-$17.69M$151.83M$120.23M$225.60M7 Day Performance-17.65%-2.13%-1.92%-1.23%1 Month Performance-20.10%-3.10%11.49%3.36%1 Year Performance27.28%11.54%30.57%16.60% Tiziana Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSATiziana Life Sciences1.2031 of 5 stars$0.78-6.9%N/A+30.8%$87.69MN/A0.008Gap DownHigh Trading VolumeCYRXCryoport3.0208 of 5 stars$7.68-0.1%$12.50+62.8%-49.8%$379.63M$226.11M-2.321,170Analyst ForecastGap DownNGNENeurogene3.7408 of 5 stars$24.81+5.5%$60.83+145.2%N/A$368.55M$925,000.000.0090PROCProcaps Group0.8894 of 5 stars$3.24+34.4%N/A-20.3%$365.54M$414.10M5.105,500News CoverageHigh Trading VolumeVYGRVoyager Therapeutics4.6114 of 5 stars$6.52+4.0%$17.00+160.7%-27.6%$356.19M$250.01M8.83100DSGNDesign Therapeutics0.9221 of 5 stars$6.28+12.1%$7.00+11.5%+143.2%$355.58MN/A-7.1840News CoveragePositive NewsBTMDbiote3.0893 of 5 stars$6.49+1.9%$9.11+40.4%+20.8%$352.65M$193.06M24.77194Positive NewsGap UpCTNMContineum Therapeutics1.9558 of 5 stars$13.64-2.8%$29.25+114.4%N/A$351.61M$50M0.0031News CoverageSLRNAcelyrin2.7884 of 5 stars$3.36+4.0%$11.75+249.7%-55.8%$337.11MN/A-1.31135KMDAKamada3.8909 of 5 stars$5.83-0.7%$14.50+148.7%-1.2%$335.11M$158.38M20.96360Positive NewsCGCCanopy Growth2.4368 of 5 stars$3.06-1.6%$3.50+14.4%-41.0%$333.36M$220.27M-0.621,029Analyst RevisionNews Coverage Related Companies and Tools Related Companies CYRX Competitors NGNE Competitors PROC Competitors VYGR Competitors DSGN Competitors BTMD Competitors CTNM Competitors SLRN Competitors KMDA Competitors CGC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLSA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLSA Stock Alerts